Plain-English translation of NCT02253030 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial uses a special imaging technique called OCT angiography—think of it as a detailed map of blood vessels in your eye—to better understand and monitor wet age-related macular degeneration (a condition that affects vision in people over 50). Researchers want to see how well this imaging can detect abnormal blood vessel growth, track how patients respond to treatment, and identify who is at risk of developing the condition.
Current methods for diagnosing and monitoring wet macular degeneration have limitations, and doctors need better tools to see exactly what's happening with the abnormal blood vessels and to predict who might develop problems. This imaging technique could help doctors make better treatment decisions and catch problems earlier.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you will either have imaging scans once before starting treatment, or you will visit the clinic monthly or every 6 months for up to 3 years for follow-up scans and eye exams. The imaging itself is painless and non-invasive—it uses light to create detailed pictures of the blood vessels in your eye. Your role is to come to appointments and allow the doctors to perform the scanning and evaluate how your condition is responding to treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States
Sponsor
Oregon Health and Science University
Enrollment target
~160 participants
Started
September 2014
Primary completion
December 2026
Age range
50 Years – 100 Years
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
George Pacheco, COA
Oregon Health and Science University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.